Authors/Disclosures
|
Nikolaos Scarmeas, MD, FAAN
(Aeginition Hospital - National and Kapodistrian University of Athens)
|
Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation . |
|
Georgios M. Hadjigeorgiou, MD
(University Hospital of Larissa)
|
No disclosure on file |
|
Alexandros Papadimitriou, MD
(University Hospital of Thessalia)
|
No disclosure on file |
|
|
No disclosure on file |
|
Bruno Dubois, MD
(Hopital La Salpetriere)
|
No disclosure on file |
|
Marie Sarazin
(Hopital De La Salpetriere)
|
No disclosure on file |
|
Jason Brandt, PhD
(Johns Hopkins School of Med)
|
No disclosure on file |
|
|
No disclosure on file |
|
Marilyn Albert
(Johns Hopkins School of Medicine)
|
Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health. |
|
|
No disclosure on file |
|
Lawrence S. Honig, MD, PhD, FAAN
(Columbia University Vagelos College of Physicians & Surgeons)
|
Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon. |
|
Pierre Labauge, MD
|
Dr. Labauge has nothing to disclose. |
|
Karen S. Marder, MD, MPH, FAAN
(Columbia University)
|
Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia. |
|
Karen Bell, MD
(Columbia University Medical Center)
|
Dr. Bell has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Bell has received research support from ACTC/NIA. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with Novartis. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with Johnson & Johnson. Dr. Bell has received personal compensation in the range of $5,000-$9,999 for serving as a Shareholder with Pfizer. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a shareholder with Baxter International. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a shareholder with Takeda. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a shareholder with Cardinal Health. |
|
Yaakov Stern, PhD
(Columbia University Medical Center)
|
Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. |